Global Artificial Heart Lung Machines Market Growth 2026-2032
The global Artificial Heart Lung Machines market size is predicted to grow from US$ 311 million in 2025 to US$ 392 million in 2032; it is expected to grow at a CAGR of 3.4% from 2026 to 2032.
Artificial Heart Lung Machines are critical medical devices used in extracorporeal circulation during surgery, temporarily replacing the functions of the heart and lungs to maintain continuous blood circulation and oxygenation. The system mainly consists of a blood pump, oxygenator, heat exchanger, tubing system, and monitoring modules, which withdraw blood from the body, oxygenate and regulate its temperature, and return it to the patient, providing safe and stable extracorporeal support for cardiac surgeries, complex major vascular procedures, and heart transplants. The core function of artificial heart lung machines is to ensure adequate tissue oxygenation and hemodynamic stability during surgery, minimizing the risks associated with cardiac arrest and hypoperfusion, thereby enhancing surgical safety and postoperative recovery. With the advancement of cardiac surgery, the adoption of minimally invasive techniques, and the promotion of precision perioperative management, artificial heart lung machines have become indispensable auxiliary devices in modern cardiac operations, also playing crucial roles in clinical research, intensive care, and heart transplantation.In 2025, global Artificial Heart Lung Machines production reached approximately 1224 Units and price is about 260 K USD/Unit.The average gross profit margin of this product is 45%.
The artificial heart lung machine market is driven by multiple factors, with the increasing global burden of cardiovascular diseases and the rising number of high-risk surgeries being primary drivers. Population aging and the rising prevalence of chronic heart conditions have increased the demand for cardiac and complex vascular surgeries, providing a stable market foundation for high-performance extracorporeal circulation devices. Meanwhile, the rapid development of minimally invasive cardiac procedures, heart transplantation, and complex major vascular surgeries has elevated requirements for device performance and reliability, driving manufacturers to continuously innovate and upgrade products. Clinical studies demonstrate that high-precision artificial heart lung machines significantly improve intraoperative hemodynamic stability, reduce organ ischemia risk, and enhance postoperative recovery, further encouraging hospitals to adopt advanced equipment. Advances in intelligent control, integrated modules, and remote monitoring technologies also create new growth opportunities in the market.
Despite technological maturity, the market faces multiple challenges. Some healthcare institutions lack awareness of the devices? value, resulting in regional disparities in deployment. High equipment costs and disposable consumables, combined with limited hospital budgets, constrain market penetration. Device operation is complex, requiring extensive training and clinical experience, which raises the adoption barrier. Additionally, factors such as blood compatibility, air embolism risk, and potential equipment malfunctions may affect surgical safety, representing inherent risks. Differences in brand performance, modularity, and maintenance convenience may also influence hospital purchasing decisions and market competition.
With the expansion and advancement of cardiac surgery, demand for artificial heart lung machines is trending toward greater intelligence, precision, and safety. Utilization is particularly pronounced in high-risk surgeries, heart transplants, and procedures for elderly patients. The growth of minimally invasive and enhanced recovery surgeries also places higher demands on device performance, controllability, and modular design. In the future, as digital operating rooms and intelligent monitoring systems become more widespread, artificial heart lung machines are expected to achieve deeper integration with surgical workstations, patient monitoring systems, and clinical information platforms, providing real-time support for intraoperative decision-making and enabling more refined perioperative management.
The upstream industry for artificial heart lung machines primarily includes high-precision blood pumps, motor and drive modules, oxygenator materials, heat exchangers, and medical tubing systems. Blood pumps and motor modules are core hardware, directly affecting circulation stability and accuracy. Oxygenator and heat exchanger materials require high standards in blood compatibility, oxygenation efficiency, and temperature regulation, while medical tubing and disposable consumables are critical for safety and biocompatibility. With advancements in medical materials science and microelectronic control technologies, upstream innovation will continue to enhance performance, safety, and intelligence, supporting product differentiation and market expansion.
LP Information, Inc. (LPI) ' newest research report, the ?Artificial Heart Lung Machines Industry Forecast? looks at past sales and reviews total world Artificial Heart Lung Machines sales in 2025, providing a comprehensive analysis by region and market sector of projected Artificial Heart Lung Machines sales for 2026 through 2032. With Artificial Heart Lung Machines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Heart Lung Machines industry.
This Insight Report provides a comprehensive analysis of the global Artificial Heart Lung Machines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Heart Lung Machines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Artificial Heart Lung Machines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Heart Lung Machines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Heart Lung Machines.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Heart Lung Machines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Artificial Heart Lung Machines are critical medical devices used in extracorporeal circulation during surgery, temporarily replacing the functions of the heart and lungs to maintain continuous blood circulation and oxygenation. The system mainly consists of a blood pump, oxygenator, heat exchanger, tubing system, and monitoring modules, which withdraw blood from the body, oxygenate and regulate its temperature, and return it to the patient, providing safe and stable extracorporeal support for cardiac surgeries, complex major vascular procedures, and heart transplants. The core function of artificial heart lung machines is to ensure adequate tissue oxygenation and hemodynamic stability during surgery, minimizing the risks associated with cardiac arrest and hypoperfusion, thereby enhancing surgical safety and postoperative recovery. With the advancement of cardiac surgery, the adoption of minimally invasive techniques, and the promotion of precision perioperative management, artificial heart lung machines have become indispensable auxiliary devices in modern cardiac operations, also playing crucial roles in clinical research, intensive care, and heart transplantation.In 2025, global Artificial Heart Lung Machines production reached approximately 1224 Units and price is about 260 K USD/Unit.The average gross profit margin of this product is 45%.
The artificial heart lung machine market is driven by multiple factors, with the increasing global burden of cardiovascular diseases and the rising number of high-risk surgeries being primary drivers. Population aging and the rising prevalence of chronic heart conditions have increased the demand for cardiac and complex vascular surgeries, providing a stable market foundation for high-performance extracorporeal circulation devices. Meanwhile, the rapid development of minimally invasive cardiac procedures, heart transplantation, and complex major vascular surgeries has elevated requirements for device performance and reliability, driving manufacturers to continuously innovate and upgrade products. Clinical studies demonstrate that high-precision artificial heart lung machines significantly improve intraoperative hemodynamic stability, reduce organ ischemia risk, and enhance postoperative recovery, further encouraging hospitals to adopt advanced equipment. Advances in intelligent control, integrated modules, and remote monitoring technologies also create new growth opportunities in the market.
Despite technological maturity, the market faces multiple challenges. Some healthcare institutions lack awareness of the devices? value, resulting in regional disparities in deployment. High equipment costs and disposable consumables, combined with limited hospital budgets, constrain market penetration. Device operation is complex, requiring extensive training and clinical experience, which raises the adoption barrier. Additionally, factors such as blood compatibility, air embolism risk, and potential equipment malfunctions may affect surgical safety, representing inherent risks. Differences in brand performance, modularity, and maintenance convenience may also influence hospital purchasing decisions and market competition.
With the expansion and advancement of cardiac surgery, demand for artificial heart lung machines is trending toward greater intelligence, precision, and safety. Utilization is particularly pronounced in high-risk surgeries, heart transplants, and procedures for elderly patients. The growth of minimally invasive and enhanced recovery surgeries also places higher demands on device performance, controllability, and modular design. In the future, as digital operating rooms and intelligent monitoring systems become more widespread, artificial heart lung machines are expected to achieve deeper integration with surgical workstations, patient monitoring systems, and clinical information platforms, providing real-time support for intraoperative decision-making and enabling more refined perioperative management.
The upstream industry for artificial heart lung machines primarily includes high-precision blood pumps, motor and drive modules, oxygenator materials, heat exchangers, and medical tubing systems. Blood pumps and motor modules are core hardware, directly affecting circulation stability and accuracy. Oxygenator and heat exchanger materials require high standards in blood compatibility, oxygenation efficiency, and temperature regulation, while medical tubing and disposable consumables are critical for safety and biocompatibility. With advancements in medical materials science and microelectronic control technologies, upstream innovation will continue to enhance performance, safety, and intelligence, supporting product differentiation and market expansion.
LP Information, Inc. (LPI) ' newest research report, the ?Artificial Heart Lung Machines Industry Forecast? looks at past sales and reviews total world Artificial Heart Lung Machines sales in 2025, providing a comprehensive analysis by region and market sector of projected Artificial Heart Lung Machines sales for 2026 through 2032. With Artificial Heart Lung Machines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Heart Lung Machines industry.
This Insight Report provides a comprehensive analysis of the global Artificial Heart Lung Machines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Heart Lung Machines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Artificial Heart Lung Machines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Heart Lung Machines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Heart Lung Machines.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Heart Lung Machines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Single Roller Pump HLM
- Double Roller Pump HLM
- Open Surgery
- Minimally Invasive
- Emergency Surgery
- General Hospitals
- Surgical Centers
- Other
- Cardiac Surgery
- Lung Transplant Operation
- Acute Respiratory Failure Treatment
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- LivaNova (Sorin)
- Getinge (Maquet)
- Medtronic
- Terumo CV Group
- Braile Biomedica
- Shenzhen Hannuo
- Fresenius
- Changzheng Medical
- What is the 10-year outlook for the global Artificial Heart Lung Machines market?
- What factors are driving Artificial Heart Lung Machines market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Artificial Heart Lung Machines market opportunities vary by end market size?
- How does Artificial Heart Lung Machines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Heart Lung Machines Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Artificial Heart Lung Machines by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Artificial Heart Lung Machines by Country/Region, 2021, 2025 & 2032
2.2 Artificial Heart Lung Machines Segment by Type
2.2.1 Single Roller Pump HLM
2.2.2 Double Roller Pump HLM
2.2.3 Artificial Heart Lung Machines Sales by Type
2.2.3.1 Global Artificial Heart Lung Machines Sales Market Share by Type (2021-2026)
2.2.3.2 Global Artificial Heart Lung Machines Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Artificial Heart Lung Machines Sale Price by Type (2021-2026)
2.3 Artificial Heart Lung Machines Segment by Surgical Type
2.3.1 Open Surgery
2.3.2 Minimally Invasive
2.3.3 Emergency Surgery
2.3.4 Artificial Heart Lung Machines Sales by Surgical Type
2.3.4.1 Global Artificial Heart Lung Machines Sales Market Share by Surgical Type (2021-2026)
2.3.4.2 Global Artificial Heart Lung Machines Revenue and Market Share by Surgical Type (2021-2026)
2.3.4.3 Global Artificial Heart Lung Machines Sale Price by Surgical Type (2021-2026)
2.4 Artificial Heart Lung Machines Segment by End Users
2.4.1 General Hospitals
2.4.2 Surgical Centers
2.4.3 Other
2.4.4 Artificial Heart Lung Machines Sales by End Users
2.4.4.1 Global Artificial Heart Lung Machines Sales Market Share by End Users (2021-2026)
2.4.4.2 Global Artificial Heart Lung Machines Revenue and Market Share by End Users (2021-2026)
2.4.4.3 Global Artificial Heart Lung Machines Sale Price by End Users (2021-2026)
2.5 Artificial Heart Lung Machines Segment by Application
2.5.1 Cardiac Surgery
2.5.2 Lung Transplant Operation
2.5.3 Acute Respiratory Failure Treatment
2.5.4 Others
2.5.5 Artificial Heart Lung Machines Sales by Application
2.5.5.1 Global Artificial Heart Lung Machines Sale Market Share by Application (2021-2026)
2.5.5.2 Global Artificial Heart Lung Machines Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Artificial Heart Lung Machines Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Artificial Heart Lung Machines Breakdown Data by Company
3.1.1 Global Artificial Heart Lung Machines Annual Sales by Company (2021-2026)
3.1.2 Global Artificial Heart Lung Machines Sales Market Share by Company (2021-2026)
3.2 Global Artificial Heart Lung Machines Annual Revenue by Company (2021-2026)
3.2.1 Global Artificial Heart Lung Machines Revenue by Company (2021-2026)
3.2.2 Global Artificial Heart Lung Machines Revenue Market Share by Company (2021-2026)
3.3 Global Artificial Heart Lung Machines Sale Price by Company
3.4 Key Manufacturers Artificial Heart Lung Machines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artificial Heart Lung Machines Product Location Distribution
3.4.2 Players Artificial Heart Lung Machines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ARTIFICIAL HEART LUNG MACHINES BY GEOGRAPHIC REGION
4.1 World Historic Artificial Heart Lung Machines Market Size by Geographic Region (2021-2026)
4.1.1 Global Artificial Heart Lung Machines Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Artificial Heart Lung Machines Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Artificial Heart Lung Machines Market Size by Country/Region (2021-2026)
4.2.1 Global Artificial Heart Lung Machines Annual Sales by Country/Region (2021-2026)
4.2.2 Global Artificial Heart Lung Machines Annual Revenue by Country/Region (2021-2026)
4.3 Americas Artificial Heart Lung Machines Sales Growth
4.4 APAC Artificial Heart Lung Machines Sales Growth
4.5 Europe Artificial Heart Lung Machines Sales Growth
4.6 Middle East & Africa Artificial Heart Lung Machines Sales Growth
5 AMERICAS
5.1 Americas Artificial Heart Lung Machines Sales by Country
5.1.1 Americas Artificial Heart Lung Machines Sales by Country (2021-2026)
5.1.2 Americas Artificial Heart Lung Machines Revenue by Country (2021-2026)
5.2 Americas Artificial Heart Lung Machines Sales by Type (2021-2026)
5.3 Americas Artificial Heart Lung Machines Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Heart Lung Machines Sales by Region
6.1.1 APAC Artificial Heart Lung Machines Sales by Region (2021-2026)
6.1.2 APAC Artificial Heart Lung Machines Revenue by Region (2021-2026)
6.2 APAC Artificial Heart Lung Machines Sales by Type (2021-2026)
6.3 APAC Artificial Heart Lung Machines Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artificial Heart Lung Machines by Country
7.1.1 Europe Artificial Heart Lung Machines Sales by Country (2021-2026)
7.1.2 Europe Artificial Heart Lung Machines Revenue by Country (2021-2026)
7.2 Europe Artificial Heart Lung Machines Sales by Type (2021-2026)
7.3 Europe Artificial Heart Lung Machines Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Heart Lung Machines by Country
8.1.1 Middle East & Africa Artificial Heart Lung Machines Sales by Country (2021-2026)
8.1.2 Middle East & Africa Artificial Heart Lung Machines Revenue by Country (2021-2026)
8.2 Middle East & Africa Artificial Heart Lung Machines Sales by Type (2021-2026)
8.3 Middle East & Africa Artificial Heart Lung Machines Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artificial Heart Lung Machines
10.3 Manufacturing Process Analysis of Artificial Heart Lung Machines
10.4 Industry Chain Structure of Artificial Heart Lung Machines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artificial Heart Lung Machines Distributors
11.3 Artificial Heart Lung Machines Customer
12 WORLD FORECAST REVIEW FOR ARTIFICIAL HEART LUNG MACHINES BY GEOGRAPHIC REGION
12.1 Global Artificial Heart Lung Machines Market Size Forecast by Region
12.1.1 Global Artificial Heart Lung Machines Forecast by Region (2027-2032)
12.1.2 Global Artificial Heart Lung Machines Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Artificial Heart Lung Machines Forecast by Type (2027-2032)
12.7 Global Artificial Heart Lung Machines Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 LivaNova (Sorin)
13.1.1 LivaNova (Sorin) Company Information
13.1.2 LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolios and Specifications
13.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 LivaNova (Sorin) Main Business Overview
13.1.5 LivaNova (Sorin) Latest Developments
13.2 Getinge (Maquet)
13.2.1 Getinge (Maquet) Company Information
13.2.2 Getinge (Maquet) Artificial Heart Lung Machines Product Portfolios and Specifications
13.2.3 Getinge (Maquet) Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Getinge (Maquet) Main Business Overview
13.2.5 Getinge (Maquet) Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Artificial Heart Lung Machines Product Portfolios and Specifications
13.3.3 Medtronic Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Terumo CV Group
13.4.1 Terumo CV Group Company Information
13.4.2 Terumo CV Group Artificial Heart Lung Machines Product Portfolios and Specifications
13.4.3 Terumo CV Group Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Terumo CV Group Main Business Overview
13.4.5 Terumo CV Group Latest Developments
13.5 Braile Biomedica
13.5.1 Braile Biomedica Company Information
13.5.2 Braile Biomedica Artificial Heart Lung Machines Product Portfolios and Specifications
13.5.3 Braile Biomedica Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Braile Biomedica Main Business Overview
13.5.5 Braile Biomedica Latest Developments
13.6 Shenzhen Hannuo
13.6.1 Shenzhen Hannuo Company Information
13.6.2 Shenzhen Hannuo Artificial Heart Lung Machines Product Portfolios and Specifications
13.6.3 Shenzhen Hannuo Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Shenzhen Hannuo Main Business Overview
13.6.5 Shenzhen Hannuo Latest Developments
13.7 Fresenius
13.7.1 Fresenius Company Information
13.7.2 Fresenius Artificial Heart Lung Machines Product Portfolios and Specifications
13.7.3 Fresenius Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Fresenius Main Business Overview
13.7.5 Fresenius Latest Developments
13.8 Changzheng Medical
13.8.1 Changzheng Medical Company Information
13.8.2 Changzheng Medical Artificial Heart Lung Machines Product Portfolios and Specifications
13.8.3 Changzheng Medical Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Changzheng Medical Main Business Overview
13.8.5 Changzheng Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Heart Lung Machines Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Artificial Heart Lung Machines by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Artificial Heart Lung Machines by Country/Region, 2021, 2025 & 2032
2.2 Artificial Heart Lung Machines Segment by Type
2.2.1 Single Roller Pump HLM
2.2.2 Double Roller Pump HLM
2.2.3 Artificial Heart Lung Machines Sales by Type
2.2.3.1 Global Artificial Heart Lung Machines Sales Market Share by Type (2021-2026)
2.2.3.2 Global Artificial Heart Lung Machines Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Artificial Heart Lung Machines Sale Price by Type (2021-2026)
2.3 Artificial Heart Lung Machines Segment by Surgical Type
2.3.1 Open Surgery
2.3.2 Minimally Invasive
2.3.3 Emergency Surgery
2.3.4 Artificial Heart Lung Machines Sales by Surgical Type
2.3.4.1 Global Artificial Heart Lung Machines Sales Market Share by Surgical Type (2021-2026)
2.3.4.2 Global Artificial Heart Lung Machines Revenue and Market Share by Surgical Type (2021-2026)
2.3.4.3 Global Artificial Heart Lung Machines Sale Price by Surgical Type (2021-2026)
2.4 Artificial Heart Lung Machines Segment by End Users
2.4.1 General Hospitals
2.4.2 Surgical Centers
2.4.3 Other
2.4.4 Artificial Heart Lung Machines Sales by End Users
2.4.4.1 Global Artificial Heart Lung Machines Sales Market Share by End Users (2021-2026)
2.4.4.2 Global Artificial Heart Lung Machines Revenue and Market Share by End Users (2021-2026)
2.4.4.3 Global Artificial Heart Lung Machines Sale Price by End Users (2021-2026)
2.5 Artificial Heart Lung Machines Segment by Application
2.5.1 Cardiac Surgery
2.5.2 Lung Transplant Operation
2.5.3 Acute Respiratory Failure Treatment
2.5.4 Others
2.5.5 Artificial Heart Lung Machines Sales by Application
2.5.5.1 Global Artificial Heart Lung Machines Sale Market Share by Application (2021-2026)
2.5.5.2 Global Artificial Heart Lung Machines Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Artificial Heart Lung Machines Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Artificial Heart Lung Machines Breakdown Data by Company
3.1.1 Global Artificial Heart Lung Machines Annual Sales by Company (2021-2026)
3.1.2 Global Artificial Heart Lung Machines Sales Market Share by Company (2021-2026)
3.2 Global Artificial Heart Lung Machines Annual Revenue by Company (2021-2026)
3.2.1 Global Artificial Heart Lung Machines Revenue by Company (2021-2026)
3.2.2 Global Artificial Heart Lung Machines Revenue Market Share by Company (2021-2026)
3.3 Global Artificial Heart Lung Machines Sale Price by Company
3.4 Key Manufacturers Artificial Heart Lung Machines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artificial Heart Lung Machines Product Location Distribution
3.4.2 Players Artificial Heart Lung Machines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ARTIFICIAL HEART LUNG MACHINES BY GEOGRAPHIC REGION
4.1 World Historic Artificial Heart Lung Machines Market Size by Geographic Region (2021-2026)
4.1.1 Global Artificial Heart Lung Machines Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Artificial Heart Lung Machines Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Artificial Heart Lung Machines Market Size by Country/Region (2021-2026)
4.2.1 Global Artificial Heart Lung Machines Annual Sales by Country/Region (2021-2026)
4.2.2 Global Artificial Heart Lung Machines Annual Revenue by Country/Region (2021-2026)
4.3 Americas Artificial Heart Lung Machines Sales Growth
4.4 APAC Artificial Heart Lung Machines Sales Growth
4.5 Europe Artificial Heart Lung Machines Sales Growth
4.6 Middle East & Africa Artificial Heart Lung Machines Sales Growth
5 AMERICAS
5.1 Americas Artificial Heart Lung Machines Sales by Country
5.1.1 Americas Artificial Heart Lung Machines Sales by Country (2021-2026)
5.1.2 Americas Artificial Heart Lung Machines Revenue by Country (2021-2026)
5.2 Americas Artificial Heart Lung Machines Sales by Type (2021-2026)
5.3 Americas Artificial Heart Lung Machines Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Heart Lung Machines Sales by Region
6.1.1 APAC Artificial Heart Lung Machines Sales by Region (2021-2026)
6.1.2 APAC Artificial Heart Lung Machines Revenue by Region (2021-2026)
6.2 APAC Artificial Heart Lung Machines Sales by Type (2021-2026)
6.3 APAC Artificial Heart Lung Machines Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artificial Heart Lung Machines by Country
7.1.1 Europe Artificial Heart Lung Machines Sales by Country (2021-2026)
7.1.2 Europe Artificial Heart Lung Machines Revenue by Country (2021-2026)
7.2 Europe Artificial Heart Lung Machines Sales by Type (2021-2026)
7.3 Europe Artificial Heart Lung Machines Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Heart Lung Machines by Country
8.1.1 Middle East & Africa Artificial Heart Lung Machines Sales by Country (2021-2026)
8.1.2 Middle East & Africa Artificial Heart Lung Machines Revenue by Country (2021-2026)
8.2 Middle East & Africa Artificial Heart Lung Machines Sales by Type (2021-2026)
8.3 Middle East & Africa Artificial Heart Lung Machines Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artificial Heart Lung Machines
10.3 Manufacturing Process Analysis of Artificial Heart Lung Machines
10.4 Industry Chain Structure of Artificial Heart Lung Machines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artificial Heart Lung Machines Distributors
11.3 Artificial Heart Lung Machines Customer
12 WORLD FORECAST REVIEW FOR ARTIFICIAL HEART LUNG MACHINES BY GEOGRAPHIC REGION
12.1 Global Artificial Heart Lung Machines Market Size Forecast by Region
12.1.1 Global Artificial Heart Lung Machines Forecast by Region (2027-2032)
12.1.2 Global Artificial Heart Lung Machines Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Artificial Heart Lung Machines Forecast by Type (2027-2032)
12.7 Global Artificial Heart Lung Machines Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 LivaNova (Sorin)
13.1.1 LivaNova (Sorin) Company Information
13.1.2 LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolios and Specifications
13.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 LivaNova (Sorin) Main Business Overview
13.1.5 LivaNova (Sorin) Latest Developments
13.2 Getinge (Maquet)
13.2.1 Getinge (Maquet) Company Information
13.2.2 Getinge (Maquet) Artificial Heart Lung Machines Product Portfolios and Specifications
13.2.3 Getinge (Maquet) Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Getinge (Maquet) Main Business Overview
13.2.5 Getinge (Maquet) Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Artificial Heart Lung Machines Product Portfolios and Specifications
13.3.3 Medtronic Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Terumo CV Group
13.4.1 Terumo CV Group Company Information
13.4.2 Terumo CV Group Artificial Heart Lung Machines Product Portfolios and Specifications
13.4.3 Terumo CV Group Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Terumo CV Group Main Business Overview
13.4.5 Terumo CV Group Latest Developments
13.5 Braile Biomedica
13.5.1 Braile Biomedica Company Information
13.5.2 Braile Biomedica Artificial Heart Lung Machines Product Portfolios and Specifications
13.5.3 Braile Biomedica Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Braile Biomedica Main Business Overview
13.5.5 Braile Biomedica Latest Developments
13.6 Shenzhen Hannuo
13.6.1 Shenzhen Hannuo Company Information
13.6.2 Shenzhen Hannuo Artificial Heart Lung Machines Product Portfolios and Specifications
13.6.3 Shenzhen Hannuo Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Shenzhen Hannuo Main Business Overview
13.6.5 Shenzhen Hannuo Latest Developments
13.7 Fresenius
13.7.1 Fresenius Company Information
13.7.2 Fresenius Artificial Heart Lung Machines Product Portfolios and Specifications
13.7.3 Fresenius Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Fresenius Main Business Overview
13.7.5 Fresenius Latest Developments
13.8 Changzheng Medical
13.8.1 Changzheng Medical Company Information
13.8.2 Changzheng Medical Artificial Heart Lung Machines Product Portfolios and Specifications
13.8.3 Changzheng Medical Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Changzheng Medical Main Business Overview
13.8.5 Changzheng Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artificial Heart Lung Machines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Artificial Heart Lung Machines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Roller Pump HLM
Table 4. Major Players of Double Roller Pump HLM
Table 5. Global Artificial Heart Lung Machines Sales by Type (2021-2026) & (Units)
Table 6. Global Artificial Heart Lung Machines Sales Market Share by Type (2021-2026)
Table 7. Global Artificial Heart Lung Machines Revenue by Type (2021-2026) & ($ million)
Table 8. Global Artificial Heart Lung Machines Revenue Market Share by Type (2021-2026)
Table 9. Global Artificial Heart Lung Machines Sale Price by Type (2021-2026) & (K US$/Unit)
Table 10. Major Players of Open Surgery
Table 11. Major Players of Minimally Invasive
Table 12. Major Players of Emergency Surgery
Table 13. Global Artificial Heart Lung Machines Sales by Surgical Type (2021-2026) & (Units)
Table 14. Global Artificial Heart Lung Machines Sales Market Share by Surgical Type (2021-2026)
Table 15. Global Artificial Heart Lung Machines Revenue by Surgical Type (2021-2026) & ($ million)
Table 16. Global Artificial Heart Lung Machines Revenue Market Share by Surgical Type (2021-2026)
Table 17. Global Artificial Heart Lung Machines Sale Price by Surgical Type (2021-2026) & (K US$/Unit)
Table 18. Major Players of General Hospitals
Table 19. Major Players of Surgical Centers
Table 20. Major Players of Other
Table 21. Global Artificial Heart Lung Machines Sales by End Users (2021-2026) & (Units)
Table 22. Global Artificial Heart Lung Machines Sales Market Share by End Users (2021-2026)
Table 23. Global Artificial Heart Lung Machines Revenue by End Users (2021-2026) & ($ million)
Table 24. Global Artificial Heart Lung Machines Revenue Market Share by End Users (2021-2026)
Table 25. Global Artificial Heart Lung Machines Sale Price by End Users (2021-2026) & (K US$/Unit)
Table 26. Global Artificial Heart Lung Machines Sale by Application (2021-2026) & (Units)
Table 27. Global Artificial Heart Lung Machines Sale Market Share by Application (2021-2026)
Table 28. Global Artificial Heart Lung Machines Revenue by Application (2021-2026) & ($ million)
Table 29. Global Artificial Heart Lung Machines Revenue Market Share by Application (2021-2026)
Table 30. Global Artificial Heart Lung Machines Sale Price by Application (2021-2026) & (K US$/Unit)
Table 31. Global Artificial Heart Lung Machines Sales by Company (2021-2026) & (Units)
Table 32. Global Artificial Heart Lung Machines Sales Market Share by Company (2021-2026)
Table 33. Global Artificial Heart Lung Machines Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Artificial Heart Lung Machines Revenue Market Share by Company (2021-2026)
Table 35. Global Artificial Heart Lung Machines Sale Price by Company (2021-2026) & (K US$/Unit)
Table 36. Key Manufacturers Artificial Heart Lung Machines Producing Area Distribution and Sales Area
Table 37. Players Artificial Heart Lung Machines Products Offered
Table 38. Artificial Heart Lung Machines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Artificial Heart Lung Machines Sales by Geographic Region (2021-2026) & (Units)
Table 42. Global Artificial Heart Lung Machines Sales Market Share Geographic Region (2021-2026)
Table 43. Global Artificial Heart Lung Machines Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Artificial Heart Lung Machines Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Artificial Heart Lung Machines Sales by Country/Region (2021-2026) & (Units)
Table 46. Global Artificial Heart Lung Machines Sales Market Share by Country/Region (2021-2026)
Table 47. Global Artificial Heart Lung Machines Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Artificial Heart Lung Machines Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units)
Table 50. Americas Artificial Heart Lung Machines Sales Market Share by Country (2021-2026)
Table 51. Americas Artificial Heart Lung Machines Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Artificial Heart Lung Machines Sales by Type (2021-2026) & (Units)
Table 53. Americas Artificial Heart Lung Machines Sales by Application (2021-2026) & (Units)
Table 54. APAC Artificial Heart Lung Machines Sales by Region (2021-2026) & (Units)
Table 55. APAC Artificial Heart Lung Machines Sales Market Share by Region (2021-2026)
Table 56. APAC Artificial Heart Lung Machines Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Artificial Heart Lung Machines Sales by Type (2021-2026) & (Units)
Table 58. APAC Artificial Heart Lung Machines Sales by Application (2021-2026) & (Units)
Table 59. Europe Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units)
Table 60. Europe Artificial Heart Lung Machines Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Artificial Heart Lung Machines Sales by Type (2021-2026) & (Units)
Table 62. Europe Artificial Heart Lung Machines Sales by Application (2021-2026) & (Units)
Table 63. Middle East & Africa Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units)
Table 64. Middle East & Africa Artificial Heart Lung Machines Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Artificial Heart Lung Machines Sales by Type (2021-2026) & (Units)
Table 66. Middle East & Africa Artificial Heart Lung Machines Sales by Application (2021-2026) & (Units)
Table 67. Key Market Drivers & Growth Opportunities of Artificial Heart Lung Machines
Table 68. Key Market Challenges & Risks of Artificial Heart Lung Machines
Table 69. Key Industry Trends of Artificial Heart Lung Machines
Table 70. Artificial Heart Lung Machines Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Artificial Heart Lung Machines Distributors List
Table 73. Artificial Heart Lung Machines Customer List
Table 74. Global Artificial Heart Lung Machines Sales Forecast by Region (2027-2032) & (Units)
Table 75. Global Artificial Heart Lung Machines Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Artificial Heart Lung Machines Sales Forecast by Country (2027-2032) & (Units)
Table 77. Americas Artificial Heart Lung Machines Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Artificial Heart Lung Machines Sales Forecast by Region (2027-2032) & (Units)
Table 79. APAC Artificial Heart Lung Machines Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Artificial Heart Lung Machines Sales Forecast by Country (2027-2032) & (Units)
Table 81. Europe Artificial Heart Lung Machines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Artificial Heart Lung Machines Sales Forecast by Country (2027-2032) & (Units)
Table 83. Middle East & Africa Artificial Heart Lung Machines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Artificial Heart Lung Machines Sales Forecast by Type (2027-2032) & (Units)
Table 85. Global Artificial Heart Lung Machines Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Artificial Heart Lung Machines Sales Forecast by Application (2027-2032) & (Units)
Table 87. Global Artificial Heart Lung Machines Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. LivaNova (Sorin) Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 89. LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolios and Specifications
Table 90. LivaNova (Sorin) Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 91. LivaNova (Sorin) Main Business
Table 92. LivaNova (Sorin) Latest Developments
Table 93. Getinge (Maquet) Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 94. Getinge (Maquet) Artificial Heart Lung Machines Product Portfolios and Specifications
Table 95. Getinge (Maquet) Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 96. Getinge (Maquet) Main Business
Table 97. Getinge (Maquet) Latest Developments
Table 98. Medtronic Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 99. Medtronic Artificial Heart Lung Machines Product Portfolios and Specifications
Table 100. Medtronic Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 101. Medtronic Main Business
Table 102. Medtronic Latest Developments
Table 103. Terumo CV Group Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 104. Terumo CV Group Artificial Heart Lung Machines Product Portfolios and Specifications
Table 105. Terumo CV Group Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 106. Terumo CV Group Main Business
Table 107. Terumo CV Group Latest Developments
Table 108. Braile Biomedica Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 109. Braile Biomedica Artificial Heart Lung Machines Product Portfolios and Specifications
Table 110. Braile Biomedica Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 111. Braile Biomedica Main Business
Table 112. Braile Biomedica Latest Developments
Table 113. Shenzhen Hannuo Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 114. Shenzhen Hannuo Artificial Heart Lung Machines Product Portfolios and Specifications
Table 115. Shenzhen Hannuo Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 116. Shenzhen Hannuo Main Business
Table 117. Shenzhen Hannuo Latest Developments
Table 118. Fresenius Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 119. Fresenius Artificial Heart Lung Machines Product Portfolios and Specifications
Table 120. Fresenius Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 121. Fresenius Main Business
Table 122. Fresenius Latest Developments
Table 123. Changzheng Medical Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 124. Changzheng Medical Artificial Heart Lung Machines Product Portfolios and Specifications
Table 125. Changzheng Medical Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 126. Changzheng Medical Main Business
Table 127. Changzheng Medical Latest Developments
Table 1. Artificial Heart Lung Machines Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Artificial Heart Lung Machines Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Roller Pump HLM
Table 4. Major Players of Double Roller Pump HLM
Table 5. Global Artificial Heart Lung Machines Sales by Type (2021-2026) & (Units)
Table 6. Global Artificial Heart Lung Machines Sales Market Share by Type (2021-2026)
Table 7. Global Artificial Heart Lung Machines Revenue by Type (2021-2026) & ($ million)
Table 8. Global Artificial Heart Lung Machines Revenue Market Share by Type (2021-2026)
Table 9. Global Artificial Heart Lung Machines Sale Price by Type (2021-2026) & (K US$/Unit)
Table 10. Major Players of Open Surgery
Table 11. Major Players of Minimally Invasive
Table 12. Major Players of Emergency Surgery
Table 13. Global Artificial Heart Lung Machines Sales by Surgical Type (2021-2026) & (Units)
Table 14. Global Artificial Heart Lung Machines Sales Market Share by Surgical Type (2021-2026)
Table 15. Global Artificial Heart Lung Machines Revenue by Surgical Type (2021-2026) & ($ million)
Table 16. Global Artificial Heart Lung Machines Revenue Market Share by Surgical Type (2021-2026)
Table 17. Global Artificial Heart Lung Machines Sale Price by Surgical Type (2021-2026) & (K US$/Unit)
Table 18. Major Players of General Hospitals
Table 19. Major Players of Surgical Centers
Table 20. Major Players of Other
Table 21. Global Artificial Heart Lung Machines Sales by End Users (2021-2026) & (Units)
Table 22. Global Artificial Heart Lung Machines Sales Market Share by End Users (2021-2026)
Table 23. Global Artificial Heart Lung Machines Revenue by End Users (2021-2026) & ($ million)
Table 24. Global Artificial Heart Lung Machines Revenue Market Share by End Users (2021-2026)
Table 25. Global Artificial Heart Lung Machines Sale Price by End Users (2021-2026) & (K US$/Unit)
Table 26. Global Artificial Heart Lung Machines Sale by Application (2021-2026) & (Units)
Table 27. Global Artificial Heart Lung Machines Sale Market Share by Application (2021-2026)
Table 28. Global Artificial Heart Lung Machines Revenue by Application (2021-2026) & ($ million)
Table 29. Global Artificial Heart Lung Machines Revenue Market Share by Application (2021-2026)
Table 30. Global Artificial Heart Lung Machines Sale Price by Application (2021-2026) & (K US$/Unit)
Table 31. Global Artificial Heart Lung Machines Sales by Company (2021-2026) & (Units)
Table 32. Global Artificial Heart Lung Machines Sales Market Share by Company (2021-2026)
Table 33. Global Artificial Heart Lung Machines Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Artificial Heart Lung Machines Revenue Market Share by Company (2021-2026)
Table 35. Global Artificial Heart Lung Machines Sale Price by Company (2021-2026) & (K US$/Unit)
Table 36. Key Manufacturers Artificial Heart Lung Machines Producing Area Distribution and Sales Area
Table 37. Players Artificial Heart Lung Machines Products Offered
Table 38. Artificial Heart Lung Machines Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Artificial Heart Lung Machines Sales by Geographic Region (2021-2026) & (Units)
Table 42. Global Artificial Heart Lung Machines Sales Market Share Geographic Region (2021-2026)
Table 43. Global Artificial Heart Lung Machines Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Artificial Heart Lung Machines Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Artificial Heart Lung Machines Sales by Country/Region (2021-2026) & (Units)
Table 46. Global Artificial Heart Lung Machines Sales Market Share by Country/Region (2021-2026)
Table 47. Global Artificial Heart Lung Machines Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Artificial Heart Lung Machines Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units)
Table 50. Americas Artificial Heart Lung Machines Sales Market Share by Country (2021-2026)
Table 51. Americas Artificial Heart Lung Machines Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Artificial Heart Lung Machines Sales by Type (2021-2026) & (Units)
Table 53. Americas Artificial Heart Lung Machines Sales by Application (2021-2026) & (Units)
Table 54. APAC Artificial Heart Lung Machines Sales by Region (2021-2026) & (Units)
Table 55. APAC Artificial Heart Lung Machines Sales Market Share by Region (2021-2026)
Table 56. APAC Artificial Heart Lung Machines Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Artificial Heart Lung Machines Sales by Type (2021-2026) & (Units)
Table 58. APAC Artificial Heart Lung Machines Sales by Application (2021-2026) & (Units)
Table 59. Europe Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units)
Table 60. Europe Artificial Heart Lung Machines Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Artificial Heart Lung Machines Sales by Type (2021-2026) & (Units)
Table 62. Europe Artificial Heart Lung Machines Sales by Application (2021-2026) & (Units)
Table 63. Middle East & Africa Artificial Heart Lung Machines Sales by Country (2021-2026) & (Units)
Table 64. Middle East & Africa Artificial Heart Lung Machines Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Artificial Heart Lung Machines Sales by Type (2021-2026) & (Units)
Table 66. Middle East & Africa Artificial Heart Lung Machines Sales by Application (2021-2026) & (Units)
Table 67. Key Market Drivers & Growth Opportunities of Artificial Heart Lung Machines
Table 68. Key Market Challenges & Risks of Artificial Heart Lung Machines
Table 69. Key Industry Trends of Artificial Heart Lung Machines
Table 70. Artificial Heart Lung Machines Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Artificial Heart Lung Machines Distributors List
Table 73. Artificial Heart Lung Machines Customer List
Table 74. Global Artificial Heart Lung Machines Sales Forecast by Region (2027-2032) & (Units)
Table 75. Global Artificial Heart Lung Machines Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Artificial Heart Lung Machines Sales Forecast by Country (2027-2032) & (Units)
Table 77. Americas Artificial Heart Lung Machines Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Artificial Heart Lung Machines Sales Forecast by Region (2027-2032) & (Units)
Table 79. APAC Artificial Heart Lung Machines Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Artificial Heart Lung Machines Sales Forecast by Country (2027-2032) & (Units)
Table 81. Europe Artificial Heart Lung Machines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Artificial Heart Lung Machines Sales Forecast by Country (2027-2032) & (Units)
Table 83. Middle East & Africa Artificial Heart Lung Machines Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Artificial Heart Lung Machines Sales Forecast by Type (2027-2032) & (Units)
Table 85. Global Artificial Heart Lung Machines Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Artificial Heart Lung Machines Sales Forecast by Application (2027-2032) & (Units)
Table 87. Global Artificial Heart Lung Machines Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. LivaNova (Sorin) Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 89. LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolios and Specifications
Table 90. LivaNova (Sorin) Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 91. LivaNova (Sorin) Main Business
Table 92. LivaNova (Sorin) Latest Developments
Table 93. Getinge (Maquet) Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 94. Getinge (Maquet) Artificial Heart Lung Machines Product Portfolios and Specifications
Table 95. Getinge (Maquet) Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 96. Getinge (Maquet) Main Business
Table 97. Getinge (Maquet) Latest Developments
Table 98. Medtronic Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 99. Medtronic Artificial Heart Lung Machines Product Portfolios and Specifications
Table 100. Medtronic Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 101. Medtronic Main Business
Table 102. Medtronic Latest Developments
Table 103. Terumo CV Group Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 104. Terumo CV Group Artificial Heart Lung Machines Product Portfolios and Specifications
Table 105. Terumo CV Group Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 106. Terumo CV Group Main Business
Table 107. Terumo CV Group Latest Developments
Table 108. Braile Biomedica Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 109. Braile Biomedica Artificial Heart Lung Machines Product Portfolios and Specifications
Table 110. Braile Biomedica Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 111. Braile Biomedica Main Business
Table 112. Braile Biomedica Latest Developments
Table 113. Shenzhen Hannuo Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 114. Shenzhen Hannuo Artificial Heart Lung Machines Product Portfolios and Specifications
Table 115. Shenzhen Hannuo Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 116. Shenzhen Hannuo Main Business
Table 117. Shenzhen Hannuo Latest Developments
Table 118. Fresenius Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 119. Fresenius Artificial Heart Lung Machines Product Portfolios and Specifications
Table 120. Fresenius Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 121. Fresenius Main Business
Table 122. Fresenius Latest Developments
Table 123. Changzheng Medical Basic Information, Artificial Heart Lung Machines Manufacturing Base, Sales Area and Its Competitors
Table 124. Changzheng Medical Artificial Heart Lung Machines Product Portfolios and Specifications
Table 125. Changzheng Medical Artificial Heart Lung Machines Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 126. Changzheng Medical Main Business
Table 127. Changzheng Medical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Artificial Heart Lung Machines
Figure 2. Artificial Heart Lung Machines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artificial Heart Lung Machines Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Artificial Heart Lung Machines Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Artificial Heart Lung Machines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Artificial Heart Lung Machines Sales Market Share by Country/Region (2025)
Figure 10. Artificial Heart Lung Machines Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Single Roller Pump HLM
Figure 12. Product Picture of Double Roller Pump HLM
Figure 13. Global Artificial Heart Lung Machines Sales Market Share by Type in 2026
Figure 14. Global Artificial Heart Lung Machines Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Open Surgery
Figure 16. Product Picture of Minimally Invasive
Figure 17. Product Picture of Emergency Surgery
Figure 18. Global Artificial Heart Lung Machines Sales Market Share by Surgical Type in 2026
Figure 19. Global Artificial Heart Lung Machines Revenue Market Share by Surgical Type (2021-2026)
Figure 20. Product Picture of General Hospitals
Figure 21. Product Picture of Surgical Centers
Figure 22. Product Picture of Other
Figure 23. Global Artificial Heart Lung Machines Sales Market Share by End Users in 2026
Figure 24. Global Artificial Heart Lung Machines Revenue Market Share by End Users (2021-2026)
Figure 25. Artificial Heart Lung Machines Consumed in Cardiac Surgery
Figure 26. Global Artificial Heart Lung Machines Market: Cardiac Surgery (2021-2026) & (Units)
Figure 27. Artificial Heart Lung Machines Consumed in Lung Transplant Operation
Figure 28. Global Artificial Heart Lung Machines Market: Lung Transplant Operation (2021-2026) & (Units)
Figure 29. Artificial Heart Lung Machines Consumed in Acute Respiratory Failure Treatment
Figure 30. Global Artificial Heart Lung Machines Market: Acute Respiratory Failure Treatment (2021-2026) & (Units)
Figure 31. Artificial Heart Lung Machines Consumed in Others
Figure 32. Global Artificial Heart Lung Machines Market: Others (2021-2026) & (Units)
Figure 33. Global Artificial Heart Lung Machines Sale Market Share by Application (2025)
Figure 34. Global Artificial Heart Lung Machines Revenue Market Share by Application in 2025
Figure 35. Artificial Heart Lung Machines Sales by Company in 2025 (Units)
Figure 36. Global Artificial Heart Lung Machines Sales Market Share by Company in 2025
Figure 37. Artificial Heart Lung Machines Revenue by Company in 2025 ($ millions)
Figure 38. Global Artificial Heart Lung Machines Revenue Market Share by Company in 2025
Figure 39. Global Artificial Heart Lung Machines Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Artificial Heart Lung Machines Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Artificial Heart Lung Machines Sales 2021-2026 (Units)
Figure 42. Americas Artificial Heart Lung Machines Revenue 2021-2026 ($ millions)
Figure 43. APAC Artificial Heart Lung Machines Sales 2021-2026 (Units)
Figure 44. APAC Artificial Heart Lung Machines Revenue 2021-2026 ($ millions)
Figure 45. Europe Artificial Heart Lung Machines Sales 2021-2026 (Units)
Figure 46. Europe Artificial Heart Lung Machines Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Artificial Heart Lung Machines Sales 2021-2026 (Units)
Figure 48. Middle East & Africa Artificial Heart Lung Machines Revenue 2021-2026 ($ millions)
Figure 49. Americas Artificial Heart Lung Machines Sales Market Share by Country in 2025
Figure 50. Americas Artificial Heart Lung Machines Revenue Market Share by Country (2021-2026)
Figure 51. Americas Artificial Heart Lung Machines Sales Market Share by Type (2021-2026)
Figure 52. Americas Artificial Heart Lung Machines Sales Market Share by Application (2021-2026)
Figure 53. United States Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Artificial Heart Lung Machines Sales Market Share by Region in 2025
Figure 58. APAC Artificial Heart Lung Machines Revenue Market Share by Region (2021-2026)
Figure 59. APAC Artificial Heart Lung Machines Sales Market Share by Type (2021-2026)
Figure 60. APAC Artificial Heart Lung Machines Sales Market Share by Application (2021-2026)
Figure 61. China Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 65. India Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Artificial Heart Lung Machines Sales Market Share by Country in 2025
Figure 69. Europe Artificial Heart Lung Machines Revenue Market Share by Country (2021-2026)
Figure 70. Europe Artificial Heart Lung Machines Sales Market Share by Type (2021-2026)
Figure 71. Europe Artificial Heart Lung Machines Sales Market Share by Application (2021-2026)
Figure 72. Germany Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 73. France Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Artificial Heart Lung Machines Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Artificial Heart Lung Machines Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Artificial Heart Lung Machines Sales Market Share by Application (2021-2026)
Figure 80. Egypt Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Artificial Heart Lung Machines in 2026
Figure 86. Manufacturing Process Analysis of Artificial Heart Lung Machines
Figure 87. Industry Chain Structure of Artificial Heart Lung Machines
Figure 88. Channels of Distribution
Figure 89. Global Artificial Heart Lung Machines Sales Market Forecast by Region (2027-2032)
Figure 90. Global Artificial Heart Lung Machines Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Artificial Heart Lung Machines Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Artificial Heart Lung Machines Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Artificial Heart Lung Machines Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Artificial Heart Lung Machines Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Artificial Heart Lung Machines
Figure 2. Artificial Heart Lung Machines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artificial Heart Lung Machines Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Artificial Heart Lung Machines Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Artificial Heart Lung Machines Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Artificial Heart Lung Machines Sales Market Share by Country/Region (2025)
Figure 10. Artificial Heart Lung Machines Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Single Roller Pump HLM
Figure 12. Product Picture of Double Roller Pump HLM
Figure 13. Global Artificial Heart Lung Machines Sales Market Share by Type in 2026
Figure 14. Global Artificial Heart Lung Machines Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Open Surgery
Figure 16. Product Picture of Minimally Invasive
Figure 17. Product Picture of Emergency Surgery
Figure 18. Global Artificial Heart Lung Machines Sales Market Share by Surgical Type in 2026
Figure 19. Global Artificial Heart Lung Machines Revenue Market Share by Surgical Type (2021-2026)
Figure 20. Product Picture of General Hospitals
Figure 21. Product Picture of Surgical Centers
Figure 22. Product Picture of Other
Figure 23. Global Artificial Heart Lung Machines Sales Market Share by End Users in 2026
Figure 24. Global Artificial Heart Lung Machines Revenue Market Share by End Users (2021-2026)
Figure 25. Artificial Heart Lung Machines Consumed in Cardiac Surgery
Figure 26. Global Artificial Heart Lung Machines Market: Cardiac Surgery (2021-2026) & (Units)
Figure 27. Artificial Heart Lung Machines Consumed in Lung Transplant Operation
Figure 28. Global Artificial Heart Lung Machines Market: Lung Transplant Operation (2021-2026) & (Units)
Figure 29. Artificial Heart Lung Machines Consumed in Acute Respiratory Failure Treatment
Figure 30. Global Artificial Heart Lung Machines Market: Acute Respiratory Failure Treatment (2021-2026) & (Units)
Figure 31. Artificial Heart Lung Machines Consumed in Others
Figure 32. Global Artificial Heart Lung Machines Market: Others (2021-2026) & (Units)
Figure 33. Global Artificial Heart Lung Machines Sale Market Share by Application (2025)
Figure 34. Global Artificial Heart Lung Machines Revenue Market Share by Application in 2025
Figure 35. Artificial Heart Lung Machines Sales by Company in 2025 (Units)
Figure 36. Global Artificial Heart Lung Machines Sales Market Share by Company in 2025
Figure 37. Artificial Heart Lung Machines Revenue by Company in 2025 ($ millions)
Figure 38. Global Artificial Heart Lung Machines Revenue Market Share by Company in 2025
Figure 39. Global Artificial Heart Lung Machines Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Artificial Heart Lung Machines Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Artificial Heart Lung Machines Sales 2021-2026 (Units)
Figure 42. Americas Artificial Heart Lung Machines Revenue 2021-2026 ($ millions)
Figure 43. APAC Artificial Heart Lung Machines Sales 2021-2026 (Units)
Figure 44. APAC Artificial Heart Lung Machines Revenue 2021-2026 ($ millions)
Figure 45. Europe Artificial Heart Lung Machines Sales 2021-2026 (Units)
Figure 46. Europe Artificial Heart Lung Machines Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Artificial Heart Lung Machines Sales 2021-2026 (Units)
Figure 48. Middle East & Africa Artificial Heart Lung Machines Revenue 2021-2026 ($ millions)
Figure 49. Americas Artificial Heart Lung Machines Sales Market Share by Country in 2025
Figure 50. Americas Artificial Heart Lung Machines Revenue Market Share by Country (2021-2026)
Figure 51. Americas Artificial Heart Lung Machines Sales Market Share by Type (2021-2026)
Figure 52. Americas Artificial Heart Lung Machines Sales Market Share by Application (2021-2026)
Figure 53. United States Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Artificial Heart Lung Machines Sales Market Share by Region in 2025
Figure 58. APAC Artificial Heart Lung Machines Revenue Market Share by Region (2021-2026)
Figure 59. APAC Artificial Heart Lung Machines Sales Market Share by Type (2021-2026)
Figure 60. APAC Artificial Heart Lung Machines Sales Market Share by Application (2021-2026)
Figure 61. China Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 65. India Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Artificial Heart Lung Machines Sales Market Share by Country in 2025
Figure 69. Europe Artificial Heart Lung Machines Revenue Market Share by Country (2021-2026)
Figure 70. Europe Artificial Heart Lung Machines Sales Market Share by Type (2021-2026)
Figure 71. Europe Artificial Heart Lung Machines Sales Market Share by Application (2021-2026)
Figure 72. Germany Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 73. France Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Artificial Heart Lung Machines Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Artificial Heart Lung Machines Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Artificial Heart Lung Machines Sales Market Share by Application (2021-2026)
Figure 80. Egypt Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Artificial Heart Lung Machines Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Artificial Heart Lung Machines in 2026
Figure 86. Manufacturing Process Analysis of Artificial Heart Lung Machines
Figure 87. Industry Chain Structure of Artificial Heart Lung Machines
Figure 88. Channels of Distribution
Figure 89. Global Artificial Heart Lung Machines Sales Market Forecast by Region (2027-2032)
Figure 90. Global Artificial Heart Lung Machines Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Artificial Heart Lung Machines Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Artificial Heart Lung Machines Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Artificial Heart Lung Machines Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Artificial Heart Lung Machines Revenue Market Share Forecast by Application (2027-2032)
